3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
2
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Dermatologic
1
Conditions
Mycosis Fungoides
1
Lymphoma, T-Cell, Cutaneous
1
Interventions
mogamulizumab
6
Cyclophosphamide
5
ruxolitinib
3
pembrolizumab
3
Immunoglobulin G
3
Disulfides
3
Biopsy
3
fludarabine
2
Specimen Handling
2
Magnetic Resonance Spectroscopy
2
Brentuximab Vedotin
2
Blood Specimen Collection
2
tofacitinib
1
sodium-iodide symporter
1
hypericin
1
fludarabine phosphate
1
cemiplimab
1
X-Rays
1
Vincristine
1
Urine Specimen Collection
1
Prednisone
1
Positron-Emission Tomography
1
Photopheresis
1
Photons
1
Nivolumab
1
Mycophenolic Acid
1
Methoxsalen
1
Mesna
1
Melphalan
1
MAC-ST-001
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Lymphoma, T-Cell, Cutaneous
×
hypericin
×
Clear all
NCT06470451
2026-04-03
FLASH2
Soligenix
Phase 3
Recruiting
80 enrolled